Preparation and evaluation of osmotic controlled release Verapamil (180 mg) tablets
Journal Title: Indian Journal of Research in Pharmacy and Biotechnology - Year 2014, Vol 2, Issue 6
Abstract
Controlled release tablets of verapamil based on osmotic technology was developed and evaluated. Verapamil half life2.8-7.4 Hrs, it is short acting drug, developed formulation provide the prolong controlled release formulations. Verapamil was chosen as a model drug with an aim to develop a controlled release system for 24 h. The developed formulation advantage of less steps of manufacturing procedure and no need of laser drilling, verapamil 180 mg core formulation was prepared using with osmogens and coating with different coating materials. The optimize film former (cellulose acetate): mechanical drilling used for pour formation. Effect of different formulation variables namely effect of osmogens. Pour size of membrane are studied. Drug release rate of verapamil directly proportional to pour size in membrane. The optimum drug release at the pour size 800µm for the optimized formulation. All excipients and polymers use in optimized formulation were found to be compatible with the drug, and compatibility study confirmed by FT-IR spectroscopy. Drug release from the optimized formulation independent not depends on concentration. The drug release mechanism follows mixed mechanism combination of diffusion and erosion mechanism. Optimized formulation of verapamil osmotic controlled release formulation compared with marketed formulation Covera HS. Drug release profile of optimized formulation amount of drug release Superior than the marketed formulation. Optimized formulation (F3) was greater than the marketed formulation.
Authors and Affiliations
Ismail Shaik, Harish G, B. Pragati Kumar, T. Abhilash
Keywords
Related Articles
- EP ID EP33267
- DOI -
- Views 235
- Downloads 0
The prescription of L-Carnitine in the treatment of Non-alcoholic fatty liver disease; A randomized and controlled clinical trial
Non-alcoholic fatty liver disease (NAFLD) consists of a range of consumption. The disease comprises clinical, Para clinical and pathological conditions from simple steatosis in non-alcoholic steatohepatitis (NASH) to f...
A REVIEW ON ENHANCEMENT OF SOLUBILITY AND DISOLUTION RATE OF BCS CLASS-II DRUG BY SOLID DISPERSION AND NONAQEOUS GRANULATION TECHNIQUE
Solid dispersion, defined as the dispersion of one or more active ingredient in a carrier or matrix at solid state, is an efficient strategy for improving dissolution of poorly water-soluble drugs for enhancement of the...
FORMULATION AND IN-VITRO EVALUATION OF TERBUTALINE SULPHATE SUSTAINED RELEASE TABLETS
Sustain release formulation maintain a constant level plasma concentration of drug so that multiple and night dosing can be avoided. Terbutaline sulphate is a β2 stimulant drug which is having a very short half life of...
Colorimetric and Kinetic method for determination of Dapsone in bulk and pharmaceutical preparations
Simple, rapid, accurate, and sensitive method for determination of dapsone in bulk and pharmaceutical preparation the method was based on reaction of 4-nitro phenol with dapsone in presence of acid medium and heating,...
Study on the growth inhibitory effects of Puromycin and Doxorubicin on tumor cell lines (A549, HepG2, HT29 and K562) using Cell Titer-Glo and Alamar blue (Resazurin) based cell viability assays
Cancer is a life-threatening spectrum of diseases in which mortality rates are high. There is more money being spent worldwide on In-vitro cancer research. Cell viability assay is the initial step to develop the antica...